<DOC>
	<DOCNO>NCT02757404</DOCNO>
	<brief_summary>Botulinum Toxin Treatment Post Stroke Upper Limb Spasticity .</brief_summary>
	<brief_title>MeditoxinÂ® Treatment Patients With Post Stroke Upper Limb Spasticity</brief_title>
	<detailed_description>This study `` A Multicenter , Prospective , Randomized , Evaluator Blinded , Comparing Phase 4 Study Evaluate Impact Injection Techniques Effectiveness Botulinum Toxin Treatment Post Stroke Upper Limb Spasticity '' .</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<criteria>1 . Male female subject age 20 . 2 . Subjects grade 1 + spasticity least one upper limb muscle measure Modified Ashworth Scale stroke . 3 . Subjects diagnose stroke least 1 month prior study participation . 4 . Subjects legal representative voluntarily decide participation study sign informed consent . 1 . Subjects spinal injury factor spasticity except stroke prior study enrollment . 2 . Subjects allergy hypersensitivity Botulinum Toxin . 3 . Subjects change muscle relaxant take treatment within past 4 week prior study participation . 4 . Subjects take injection treatment use alcohol phenol upper limb within past 6 month prior study participation . 5 . Subjects general neuromuscular synaptic disorder ( e.g . Myasthenia gravis , LambertEaton syndrome , Amyotrophic lateral sclerosis ) . 6 . Subjects inject botulinum toxin within past 3 month injection . 7 . Subjects pregnant lactate disagreed avoid pregnancy 3 month study period . 8 . Subjects schedule take part clinical trial study period . 9 . Patients eligible study medical discretion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>botulinum toxin</keyword>
	<keyword>spasticity</keyword>
	<keyword>injection technique</keyword>
	<keyword>neuronox</keyword>
	<keyword>meditoxin</keyword>
</DOC>